Correlation between Serum FGF-23, HPSE Levels and Early Renal Impairment in Patients with Multiple Myeloma.
10.19746/j.cnki.issn.1009-2137.2025.03.029
- Author:
Li-Fang MA
1
;
Yan YUN
1
;
Yan-Qi LIU
1
;
Xue-Qin BAI
1
;
Wen-Juan NI
1
;
Zhi-Qin LI
1
;
Yan LU
1
;
Zhe LI
1
;
Jing LI
1
;
Guo-Rong JIA
1
Author Information
1. Department of Hematology, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014010, Inner Mongolia Autonomous Region, China.
- Publication Type:Journal Article
- Keywords:
multiple myeloma;
early renal impairment;
fibroblast growth factor-23;
heparanase
- MeSH:
Humans;
Multiple Myeloma/complications*;
Fibroblast Growth Factor-23;
Retrospective Studies;
Fibroblast Growth Factors/blood*;
Glucuronidase/blood*;
Male;
Female;
Middle Aged;
Renal Insufficiency/blood*;
Aged
- From:
Journal of Experimental Hematology
2025;33(3):822-827
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the relationship between serum levels of fibroblast growth factor-23 (FGF-23), heparanase (HPSE) and early renal impairment (RI) in patients with multiple myeloma (MM).
METHODS:A retrospective analysis was conducted on the clinical data of 125 MM patients who were initially diagnosed in the Department of Hematology of the First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology from June 2020 to June 2023. The patients were divided into RI group (>176.80 μmol/L) and non-RI group (≤176.80 μmol/L) based on their serum creatinine levels when diagnosed. The baseline data and laboratory indexes of the two groups were compared. The relationship between serum FGF-23, HPSE and early RI in MM patients was analyzed.
RESULTS:Among 125 newly diagnosed MM patients, 33 cases developed early RI, accounting for 26.40%. The proportion of light chain type, blood urea nitrogen (BUN), blood uric acid, lactate dehydrogenase, FGF-23, and HPSE levels in RI group were higher than those in non-RI group (all P <0.05). There was no statistical significant difference in other data between the two groups (P >0.05). Multivariate logistic regression analysis showed that BUN, FGF-23 and HPSE were associated with early RI in MM patients (all P <0.05). The serum FGF-23 level was divided into Q1-Q4 groups by quartile, and the serum HPSE level was divided into q1-q4 groups. The correlation analysis showed that with the increase of serum FGF-23 and HPSE levels, the incidence of early RI increased (r =0.668, 0.592). Furthermore, logistic regression analysis showed that after controlling for confounding factors, elevated levels of serum FGF-23 and HPSE were still influencing factors for early RI in MM patients (OR>1, P <0.05). According to Pearson's linear correlation test, there was a positive correlation between serum FGF-23 level and HPSE level (r =0.373).
CONCLUSION:There is a certain correlation between serum levels of FGF-23, HPSE and early RI in MM patients, and the incidence of early RI is higher in patients with abnormally high levels of both.
